Francisco Lopera

605 total citations
19 papers, 96 citations indexed

About

Francisco Lopera is a scholar working on Psychiatry and Mental health, Physiology and Molecular Biology. According to data from OpenAlex, Francisco Lopera has authored 19 papers receiving a total of 96 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 6 papers in Physiology and 4 papers in Molecular Biology. Recurrent topics in Francisco Lopera's work include Dementia and Cognitive Impairment Research (7 papers), Alzheimer's disease research and treatments (6 papers) and Functional Brain Connectivity Studies (4 papers). Francisco Lopera is often cited by papers focused on Dementia and Cognitive Impairment Research (7 papers), Alzheimer's disease research and treatments (6 papers) and Functional Brain Connectivity Studies (4 papers). Francisco Lopera collaborates with scholars based in Colombia, United States and United Kingdom. Francisco Lopera's co-authors include Ana Baena, Yakeel T. Quiroz, Daniel Norton, Yamile Bocanegra, Enmanuelle Pardilla‐Delgado, Nelson David Villalba‐Moreno, Kewei Chen, Pierre N. Tariot, Alain Artola and Bernard Hanseeuw and has published in prestigious journals such as Frontiers in Immunology, Neurobiology of Aging and The Gerontologist.

In The Last Decade

Francisco Lopera

16 papers receiving 95 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francisco Lopera Colombia 6 55 37 20 17 14 19 96
Raffaele Di Lorenzo Italy 6 35 0.6× 39 1.1× 8 0.4× 19 1.1× 35 2.5× 10 111
Jane Douglas United Kingdom 3 51 0.9× 36 1.0× 25 1.3× 6 0.4× 19 1.4× 3 93
Moa Wibom Sweden 3 79 1.4× 60 1.6× 19 0.9× 17 1.0× 21 1.5× 4 98
Melissa McSweeney Canada 5 50 0.9× 40 1.1× 17 0.8× 14 0.8× 6 0.4× 7 100
Marcel Lévy France 5 21 0.4× 23 0.6× 16 0.8× 13 0.8× 9 0.6× 8 104
Sonia Moreno–Grau Spain 5 35 0.6× 34 0.9× 13 0.7× 5 0.3× 32 2.3× 11 93
Cécilia Marelli France 4 60 1.1× 29 0.8× 7 0.3× 26 1.5× 13 0.9× 4 92
Lucia Princiotta Cariddi Italy 6 40 0.7× 14 0.4× 12 0.6× 17 1.0× 41 2.9× 9 143
Sarah Westwood United Kingdom 2 68 1.2× 41 1.1× 5 0.3× 15 0.9× 29 2.1× 3 95
Tom Montine United States 4 31 0.6× 52 1.4× 27 1.4× 3 0.2× 12 0.9× 5 104

Countries citing papers authored by Francisco Lopera

Since Specialization
Citations

This map shows the geographic impact of Francisco Lopera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francisco Lopera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francisco Lopera more than expected).

Fields of papers citing papers by Francisco Lopera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francisco Lopera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francisco Lopera. The network helps show where Francisco Lopera may publish in the future.

Co-authorship network of co-authors of Francisco Lopera

This figure shows the co-authorship network connecting the top 25 collaborators of Francisco Lopera. A scholar is included among the top collaborators of Francisco Lopera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francisco Lopera. Francisco Lopera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Tripathi, Vaibhav, Joshua T. Fox‐Fuller, Ana Baena, et al.. (2025). Connectome‐based predictive modeling of brain pathology and cognition in autosomal dominant Alzheimer's disease. Alzheimer s & Dementia. 21(3). e70061–e70061. 1 indexed citations
2.
Sanchez, Justin S., Nelson David Villalba‐Moreno, Claudia Mariño, et al.. (2024). APOE3 Christchurch modulates β-catenin/Wnt signaling in iPS cell-derived cerebral organoids from Alzheimer’s cases. Frontiers in Molecular Neuroscience. 17. 1373568–1373568. 15 indexed citations
3.
Littau, Jessica Lisa, et al.. (2023). Proteomic characterization of small vessel pathology in PSEN1 E280A familial Alzheimer’s disease. Alzheimer s & Dementia. 19(S24).
4.
5.
Lopera, Francisco, et al.. (2023). Creativity During COVID-19: Evaluating an Online TimeSlips Storytelling Program for People Living With Dementia During Quarantine in Colombia. The Gerontologist. 63(8). 1279–1288. 2 indexed citations
6.
Toledo, Jorge, Jessica Lisa Littau, Steffen Härtel, et al.. (2022). Gliovascular alterations in sporadic and familial Alzheimer's disease: APOE3 Christchurch homozygote glioprotection. Brain Pathology. 33(2). e13119–e13119. 7 indexed citations
7.
Bubak, Andrew N., Vijay R. Ramakrishnan, Lucía Madrigal, et al.. (2022). Signatures for viral infection and inflammation in the proximal olfactory system in familial Alzheimer's disease. Neurobiology of Aging. 123. 75–82. 8 indexed citations
9.
Bartolomé, Fernando Benito, Luigi Rosa, Piera Valenti, et al.. (2022). Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer’s Disease Patients. Frontiers in Immunology. 13. 878201–878201. 7 indexed citations
10.
Fernández, Gerardo, Luis Méndez, Francisco Lopera, & Mario A. Parra. (2022). The eye as a biomarker for Alzheimer’s disease: oculomotor behaviours yield a novel digital biomarker for preclinical risk detection. Alzheimer s & Dementia. 18(S5). 1 indexed citations
11.
Parra, Mario A., Pavel Prado, Sebastián Moguilner, et al.. (2022). The EuroLaD‐EEG consortium: towards a global EEG platform for dementia, for seeking to reduce the regional impact of dementia. Alzheimer s & Dementia. 18(S6). 1 indexed citations
12.
Littau, Jessica Lisa, Lina Velilla, Yoshiki Hase, et al.. (2022). Evidence of beta amyloid independent small vessel disease in familial Alzheimer's disease. Brain Pathology. 32(6). e13097–e13097. 9 indexed citations
13.
Calandri, Ismael Luis, Lucía Crivelli, Paulo Caramelli, et al.. (2022). LatAm FINGERS: Overcoming Barriers for a Dementia Prevention Trial Startup. Alzheimer s & Dementia. 18(S11). 1 indexed citations
15.
Fox‐Fuller, Joshua T., Alice Cronin‐Golomb, Jennifer R. Gatchel, et al.. (2019). Biological and Cognitive Markers of Presenilin1 E280A Autosomal Dominant Alzheimer's Disease: A Comprehensive Review of the Colombian Kindred. The Journal of Prevention of Alzheimer s Disease. 6(2). 112–120. 32 indexed citations
16.
Vargas‐González, Juan‐Camilo, et al.. (2014). P3‐256: VALIDATION OF THE INECO FRONTAL SCREENING IN A COLOMBIAN POPULATION. Alzheimer s & Dementia. 10(4S_Part_20). 4 indexed citations
17.
Tariot, Pierre N., Carole Ho, Carolyn Langlois, et al.. (2014). FTS‐03‐02: THE ALZHEIMER'S PREVENTION INITIATIVE. Alzheimer s & Dementia. 10(4S_Part_4). 4 indexed citations
18.
19.
Quiroz, Yakeel T., Chantal E. Stern, Eric M. Reiman, et al.. (2011). P1‐338: Cortical signature of Alzheimer's disease‐related thinning in presymptomatic presenilin‐1 mutation carriers. Alzheimer s & Dementia. 7(4S_Part_6). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026